Should people who have previously been treated for joint bleeding be given regular preventative treatment with clotting factor concentrates to manage their condition? Read this @CochraneLibrary @cochranecfgd systematic review w/ evidence from 10 RCTs: ht
RT @WileyHealth: Should people who have previously been treated for joint bleeding be given regular preventative treatment with clotting fa…
RT @WileyHealth: Should people who have previously been treated for joint bleeding be given regular preventative treatment with clotting fa…
Should people who have previously been treated for joint bleeding be given regular preventative treatment with clotting factor concentrates to manage their condition? Read this @CochraneLibrary @cochranecfgd systematic review w/ evidence from 10 RCTs: ht
Should people, who have previously been treated for joint bleeding, be given regular preventative treatment with clotting factor concentrates to manage their condition? https://t.co/4X2WL6Koss New @cochranecfgd systematic review looks at the evidence of 10
RT @CochraneUK: Should people, who have previously been treated for joint bleeding, be given regular preventative treatment with clotting f…
RT @CochraneUK: Should people, who have previously been treated for joint bleeding, be given regular preventative treatment with clotting f…
RT @CochraneLibrary: Should people, who have previously been treated for joint bleeding, be given regular preventative treatment with clott…
RT @CochraneLibrary: Should people, who have previously been treated for joint bleeding, be given regular preventative treatment with clott…
Should people, who have previously been treated for joint bleeding, be given regular preventative treatment with clotting factor concentrates to manage their condition?https://t.co/jCohJTVKvB New @cochranecfgd systematic review looks at the evidence of 10
RT @cochranecfgd: New #CochraneEvidence: Clotting factor concentrates for preventing bleeding and bleeding‐related complications in previou…
New #CochraneEvidence: Clotting factor concentrates for preventing bleeding and bleeding‐related complications in previously treated individuals with haemophilia A or B https://t.co/eAF7odtL9u